> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Meeting on Including Pregnant Women in Clinical Trials
- URL: https://www.fdaweb.com/meeting-on-including-pregnant-women-in-clinical-trials/
- Published: 2020-03-12T12:00:00.000Z
- Updated: 2026-09-14T16:06:59.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5146310

*Federal Register* notice: FDA has announced a 4/16 public meeting entitled “Scientific and Ethical Considerations for the Inclusion of Pregnant Women in Clinical Trials.” The meeting will be convened by Duke University’s Robert J. Margolis, Center for Health Policy (Duke-Margolis) under a cooperative agreement with FDA. It is intended to gather stakeholder input on the scientific and ethical issues that surround pregnant women being included in clinical trials for drug development. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2020-03-11/pdf/2020-04990.pdf?ref=fdaweb.com).